AssetMark Inc’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-9,839
| Closed | -$977K | – | 1524 |
|
|
2019
Q3 | $977K | Buy |
9,839
+5,366
| +120% | +$510K | 0.01% | 316 |
|
|
2019
Q2 | $413K | Sell |
4,473
-790
| -15% | -$75K | ﹤0.01% | 379 |
|
|
2019
Q1 | $497K | Sell |
5,263
-1,040
| -17% | -$91K | ﹤0.01% | 345 |
|
|
2018
Q4 | $404K | Buy |
6,303
+81
| +1% | +$5.98K | ﹤0.01% | 362 |
|
|
2018
Q3 | $557K | Buy |
6,222
+165
| +3% | +$14.6K | 0.01% | 342 |
|
|
2018
Q2 | $481K | Sell |
6,057
-973
| -14% | -$80.8K | ﹤0.01% | 354 |
|
|
2018
Q1 | $627K | Sell |
7,030
-3,595
| -34% | -$345K | 0.01% | 327 |
|
|
2017
Q4 | $1.11M | Buy |
10,625
+1,215
| +13% | +$137K | 0.01% | 292 |
|
|
2017
Q3 | $1.37M | Sell |
9,410
-424
| -4% | -$57.8K | 0.02% | 274 |
|
|
2017
Q2 | $1.28M | Buy |
9,834
+593
| +6% | +$72.7K | 0.02% | 271 |
|
|
2017
Q1 | $1.15M | Sell |
9,241
-722
| -7% | -$86.4K | 0.02% | 277 |
|
|
2016
Q4 | $1.15M | Sell |
9,963
-582
| -6% | -$64.8K | 0.02% | 255 |
|
|
2016
Q3 | $1.1M | Sell |
10,545
-202
| -2% | -$21.9K | 0.02% | 249 |
|
|
2016
Q2 | $1.06M | Sell |
10,747
-5,325
| -33% | -$551K | 0.02% | 259 |
|
|
2016
Q1 | $1.61M | Sell |
16,072
-1,211
| -7% | -$125K | 0.03% | 231 |
|
|
2015
Q4 | $2.07M | Buy |
17,283
+16,567
| +2,314% | +$1.92M | 0.04% | 211 |
|
|
2015
Q3 | $77K | Buy |
716
+445
| +164% | +$55.2K | ﹤0.01% | 362 |
|
|
2015
Q2 | $31K | Buy |
+271
| New | +$31K | ﹤0.01% | 441 |
|
Other funds holding CELG
AssetMark Inc's CELG Position: Q4 2019 in Review
AssetMark Inc sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 9,839 shares — an estimated $977K sold.
AssetMark Inc first reported a position in CELG in Q2 2015 and held it in 18 quarters. The position peaked at $2.07M in Q4 2015. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- AssetMark Inc reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- AssetMark Inc sold 9,839 Celgene Corp shares in Q4 2019, an estimated $977K.
- AssetMark Inc first reported a position in Celgene Corp in Q2 2015 and held it in 18 quarters.
- AssetMark Inc's Celgene Corp position peaked at $2.07M in Q4 2015.
- 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on AssetMark Inc's 13F filing for Q4 2019, filed 11 Feb 2020.